Mesoblast Limited has grown revenue −38% a year over three years and −15% a year over five. Revenue growth, 3-year annual rate: −38% (Biotechnology median +21%). Revenue growth, 5-year rate: −15%, growth has slowed since the five-year average. Years of annual history on file: 10, FY2016 to FY2025, as filed.

MESOMesoblast Limited

HealthcareUSD

$16.83

$12.8852 weeks$20.96

Is it growing?

Is MESO growing?

Mesoblast Limited has grown revenue −38% a year over three years and −15% a year over five.

−38%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −15%
Revenue growth, 5-year rate · −38% over three · growth has slowed since the five-year average
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed

Details›